Search Results - "Sravya, Palavalasa"
-
1
Differential gene expression in peritumoral brain zone of glioblastoma: role of SERPINA3 in promoting invasion, stemness and radioresistance of glioma cells and association with poor patient prognosis and recurrence
Published in Journal of neuro-oncology (01-03-2021)“…Purpose Glioblastoma (GBM) is a highly invasive tumor. Despite advances in treatment modalities, tumor recurrence is common, seen mainly in the peritumoral…”
Get full text
Journal Article -
2
L1CAM Immunopositivity in Anaplastic Supratentorial Ependymomas: Correlation With Clinical and Histological Parameters
Published in International journal of surgical pathology (01-05-2019)“…Supratentorial ependymomas (ST EPNs) are molecularly characterized, of which the RELA fusion positive tumors are the most common and aggressive subgroup…”
Get full text
Journal Article -
3
Purine salvage promotes treatment resistance in H3K27M-mutant diffuse midline glioma
Published in Cancer & metabolism (09-04-2024)“…Diffuse midline gliomas (DMG), including diffuse intrinsic pontine gliomas (DIPGs), are a fatal form of brain cancer. These tumors often carry a driver…”
Get full text
Journal Article -
4
Granular cells in oligodendroglioma suggest a neoplastic change rather than a reactive phenomenon: case report with molecular characterisation
Published in Brain tumor pathology (2017)“…Oligodendrogliomas are diffuse gliomas characterised by IDH mutation and 1p/19q co-deletion. Classical oligodendrocytes, minigemistocytes, gliofibrillary…”
Get full text
Journal Article -
5
Prognostic Factors and Outcomes in World Health Organization Grade 1 and Grade 2 Intracranial Meningiomas—5-Year Institutional Experience
Published in World neurosurgery (01-07-2024)“…Meningiomas are the most frequent primary intracranial tumor. While histological grade and grade of excision are established predictors of recurrence, the…”
Get full text
Journal Article -
6
DNAR-08. THY1 MEDIATES TREATMENT RESISTANCE IN GLIOBLASTOMA THROUGH RAPID REPAIR OF DNA DAMAGE
Published in Neuro-oncology (Charlottesville, Va.) (11-11-2024)“…Glioblastoma (GBM) is a uniformly lethal primary intracranial neoplasm that inevitably recurs despite treatment by DNA damaging agents radiation (RT) and…”
Get full text
Journal Article -
7
Glioma, glutamate (SLC7A11) and seizures-a commentary
Published in Annals of translational medicine (01-05-2017)Get full text
Journal Article -
8
IMMU-04. G-AMINOBUTYRIC ACID DRIVES GLIOBLASTOMA IN FEMALES IN AN IMMUNE-DEPENDENT MANNER
Published in Neuro-oncology (Charlottesville, Va.) (11-11-2024)“…Communication with a neuronal network and accumulation of myeloid-derived suppressive cells (MDSCs) support GBM growth and therapeutic resistance. GBM…”
Get full text
Journal Article -
9
TMIC-25. MICROGLIA IN THE GLIOBLASTOMA MICROENVIRONMENT SECRETE ACETYLATED AMINO ACIDS WHICH ASSIST IN THE REPAIR OF RADIATION INDUCED DNA DAMAGE
Published in Neuro-oncology (Charlottesville, Va.) (11-11-2024)“…Rapid repair of DNA damage mediates genotoxic therapy resistance and poor prognosis in glioblastoma (GBM). The GBM tumor microenvironment (TME) is…”
Get full text
Journal Article -
10
DNAR-02. MICROGLIA IN THE GLIOBLASTOMA MICROENVIRONMENT ASSIST REPAIR OF RADIATION INDUCED DNA DAMAGE IN A CONTACT INDEPENDENT MANNER
Published in Neuro-oncology (Charlottesville, Va.) (10-11-2023)“…Rapid repair of DNA damage mediates genotoxic therapy resistance and poor prognosis in glioblastoma (GBM). The GBM tumor microenvironment (TME) is…”
Get full text
Journal Article -
11
TMET-03. REPROGRAMMING OF GLIOBLASTOMA GLUCOSE METABOLISM FUELS TUMOR GROWTH
Published in Neuro-oncology (Charlottesville, Va.) (10-11-2023)“…Metabolic adaptation can promote oncogenic phenotypes in glioblastoma (GBM), but the metabolic pathways utilized by GBM and how they differ from the pathways…”
Get full text
Journal Article -
12
Chitinase 3-Like 2: A Novel Biomarker Expressed in Peritumoral Brain Zone of Glioblastoma is associated With tumor recurrence and Poor Patient Prognosis
Published in American journal of clinical pathology (01-10-2022)“…Objectives: We aimed to evaluate the expression pattern of chitinase 3-like 2 (CHI3L2) in the tumor core and peritumoral brain zone (PBZ) of newly diagnosed…”
Get full text
Journal Article -
13
Chitinase 3-Like 2
Published in American journal of clinical pathology (06-10-2022)“…Abstract Objectives We aimed to evaluate the expression pattern of chitinase 3-like 2 (CHI3L2) in the tumor core and peritumoral brain zone (PBZ) of newly…”
Get full text
Journal Article -
14
Abstract 1789: Machine learning-based method to analyze metabolic fluxes of patient tumors
Published in Cancer research (Chicago, Ill.) (22-03-2024)“…Personalized oncology must overcome the complex challenge of distinct cancer phenotypes in each patient, formed in part in response to unique metabolic…”
Get full text
Journal Article -
15
TMET-19. REWIRING OF CORTICAL GLUCOSE METABOLISM FUELS HUMAN BRAIN CANCER GROWTH
Published in Neuro-oncology (Charlottesville, Va.) (11-11-2024)“…The brain avidly consumes glucose to fuel neurophysiology. Cancers of the brain, such as glioblastoma (GBM), lose aspects of normal biology and gain the…”
Get full text
Journal Article -
16
TMET-27. MACHINE LEARNING-BASED IDENTIFICATION OF METABOLIC FLUXES IN PATIENT BRAIN TUMORS
Published in Neuro-oncology (Charlottesville, Va.) (11-11-2024)“…Personalized oncology aims to match effective treatments for individual cancer patients based on the biology of an individual tumor. This approach is not…”
Get full text
Journal Article -
17
TMET-28. RECIPROCAL LINKS BETWEEN METHIONINE METABOLISM, DNA REPAIR AND THERAPY RESISTANCE IN GLIOBLASTOMA
Published in Neuro-oncology (Charlottesville, Va.) (11-11-2024)“…Glioblastoma (GBM) is uniformly lethal due to profound treatment resistance. Altered cellular metabolism is a key mediator of GBM treatment resistance. Uptake…”
Get full text
Journal Article -
18
IRX1 is a novel gene, overexpressed in high-grade IDH-mutant astrocytomas
Published in Pathology, research and practice (01-05-2023)“…IDH-mutant astrocytomas include CNS WHO grade 2 (A2), grade 3 (A3) and grade 4 (A4), of which A3 and A4 are high-grade. A3 has a heterogenous clinical outcome…”
Get full text
Journal Article -
19
CBMT-24. MITOCHONDRIAL DNA CONTENT IN GLIOBLASTOMA AND ITS CLINICAL SIGNIFICANCE
Published in Neuro-oncology (Charlottesville, Va.) (05-11-2018)“…Abstract Evidence of altered mitochondrial DNA (mtDNA) content in several malignancies has surfaced in recent years. However, in glioblastoma, this aspect…”
Get full text
Journal Article -
20
Low mitochondrial DNA copy number is associated with poor prognosis and treatment resistance in glioblastoma
Published in Mitochondrion (01-11-2020)“…•Mitochondrial DNA (mtDNA) copy number is a prognostic marker in glioblastoma (GBM).•Low mtDNA copy number in GBM is associated with poor prognosis.•Recurrent…”
Get full text
Journal Article